Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Diamond-Blackfan Anemia: early-phase trial registry
6 of 12 indexed Diamond-Blackfan Anemia trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,429 of 28,707 conditions by registered trial count.
12 US clinical trials · 6 currently recruiting · #1,429 of 28,707 conditions by registered trial count
Diamond-Blackfan Anemia: 12 US clinical trials tracked, 6 recruiting.
Diamond-Blackfan Anemia is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is St. Jude Children's Research Hospital, running 3 of these trials.
Enrollment posture brief
Registry condition diamond-blackfan-anemia
OPEN 6 | RECR 50% | LATE 0 | EARLY 5 | RANK #1429 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Diamond-Blackfan Anemia lists 6 open slots (50% of 12 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Diamond-Blackfan Anemia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Diamond-Blackfan Anemia is recruiting above its size-band peers.
6 of 12 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Diamond-Blackfan Anemia research.
St. Jude Children's Research Hospital accounts for 3 of 12 trials (25%). 9 distinct sponsors appear on at least one study for this condition label.
-
Most Diamond-Blackfan Anemia trials plan to enrol fewer than 100 people.
Median target enrolment is 37 among the 12 trials that report a genuine target (sentinel values excluded). 8 of those (66.7%) plan for fewer than 100 participants.
-
Diamond-Blackfan Anemia splits between interventional and observational designs.
6 interventional and 6 observational studies make up this index (50% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
12 total, page 1 of 1
Cancer in Inherited Bone Marrow Failure Syndromes
National Cancer Institute (NCI)
NCT00027274
Investigation of the Genetics of Hematologic Diseases
St. Jude Children's Research Hospital
NCT02720679
Familial Investigations of Childhood Cancer Predisposition
St. Jude Children's Research Hospital
NCT03050268
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
Mitchell Cairo
NCT04099966
Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS)
Northwell Health
NCT07186179
T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
Paul Szabolcs
NCT03653338
CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation
Diane George
NCT01966367
Multi-Center Study of Iron Overload: Survey Study (MCSIO)
UCSF Benioff Children's Hospital Oakland
NCT01913548
Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission
University of California, San Francisco
NCT00305708
Stem Cell Transplant for Hemoglobinopathy
Masonic Cancer Center, University of Minnesota
NCT00176852
Multi-Center Study of Iron Overload: Pilot Study
UCSF Benioff Children's Hospital Oakland
NCT01114776
Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias
St. Jude Children's Research Hospital
NCT00244010
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Diamond-Blackfan Anemia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Diamond-Blackfan Anemia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Diamond-Blackfan Anemia page
12 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Diamond-Blackfan Anemia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- St. Jude Children's Research Hospital sponsors the most Diamond-Blackfan Anemia trials on record, review their full trial history before evaluating a specific study. See St. Jude Children's Research Hospital's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diamond-Blackfan Anemia condition card totals 12 registered trials; most-linked intervention Campath, Fludarabine, Cyclophosphamide; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.